Literature DB >> 12634355

Hepatitis C virus NS3 ATPases/helicases from different genotypes exhibit variations in enzymatic properties.

Angela M I Lam1, David Keeney, Patrick Q Eckert, David N Frick.   

Abstract

The NS3 ATPase/helicase was isolated and characterized from three different infectious clones of hepatitis C virus (HCV). One helicase was from a genotype that normally responds to therapy (Hel-2a), and the other two were from more resistant genotypes, 1a (Hel-1a) and 1b (Hel-1b). Although the differences among these helicases are generally minor, all three enzymes have distinct properties. Hel-1a is less selective for nucleoside triphosphates, Hel-1b hydrolyzes nucleoside triphosphates less rapidly, and Hel-2a unwinds DNA more rapidly and binds DNA more tightly than the other two enzymes. Unlike related proteins, different nucleic acid sequences stimulate ATP hydrolysis by HCV helicase at different maximum rates and with different apparent efficiencies. This nucleic acid stimulation profile is conserved among the enzymes, but it does not result entirely from differential DNA-binding affinities. Although the amino acid sequences of the three proteins differ by up to 15%, one variant amino acid that is critical for helicase action was identified. NS3 residue 450 is a threonine in Hel-1a and Hel-1b and is an isoleucine in Hel-2a. A mutant Hel-1a with an isoleucine substituted for threonine 450 unwinds DNA more rapidly and binds DNA more tightly than the parent protein.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12634355      PMCID: PMC150621          DOI: 10.1128/jvi.77.7.3950-3961.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  45 in total

1.  Comparative characterization of two DEAD-box RNA helicases in superfamily II: human translation-initiation factor 4A and hepatitis C virus non-structural protein 3 (NS3) helicase.

Authors:  Mark X Du; Robert B Johnson; Xin-Lai Sun; Kirk A Staschke; Joseph Colacino; Q May Wang
Journal:  Biochem J       Date:  2002-04-01       Impact factor: 3.857

Review 2.  Ribavirin's antiviral mechanism of action: lethal mutagenesis?

Authors:  Shane Crotty; Craig Cameron; Raul Andino
Journal:  J Mol Med (Berl)       Date:  2001-12-04       Impact factor: 4.599

3.  Helicase from hepatitis C virus, energetics of DNA binding.

Authors:  Mikhail K Levin; Smita S Patel
Journal:  J Biol Chem       Date:  2002-05-28       Impact factor: 5.157

4.  The hepatitis C viral NS3 protein is a processive DNA helicase with cofactor enhanced RNA unwinding.

Authors:  Phillip S Pang; Eckhard Jankowsky; Paul J Planet; Anna Marie Pyle
Journal:  EMBO J       Date:  2002-03-01       Impact factor: 11.598

5.  Sequence variation in the gene encoding the nonstructural 3 protein of hepatitis C virus: evidence for immune selection.

Authors:  Huiru Wang; Tonghua Bian; Stephen J Merrill; David D Eckels
Journal:  J Mol Evol       Date:  2002-04       Impact factor: 2.395

Review 6.  Clinical significance of hepatitis C virus genotypes.

Authors:  N N Zein
Journal:  Clin Microbiol Rev       Date:  2000-04       Impact factor: 26.132

7.  Dual divalent cation requirement of the MutT dGTPase. Kinetic and magnetic resonance studies of the metal and substrate complexes.

Authors:  D N Frick; D J Weber; J R Gillespie; M J Bessman; A S Mildvan
Journal:  J Biol Chem       Date:  1994-01-21       Impact factor: 5.157

8.  Persistent hepatitis C virus infection in a chimpanzee is associated with emergence of a cytotoxic T lymphocyte escape variant.

Authors:  A Weiner; A L Erickson; J Kansopon; K Crawford; E Muchmore; A L Hughes; M Houghton; C M Walker
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

9.  Hepatitis C virus NS3 protein polynucleotide-stimulated nucleoside triphosphatase and comparison with the related pestivirus and flavivirus enzymes.

Authors:  J A Suzich; J K Tamura; F Palmer-Hill; P Warrener; A Grakoui; C M Rice; S M Feinstone; M S Collett
Journal:  J Virol       Date:  1993-10       Impact factor: 5.103

10.  Two related superfamilies of putative helicases involved in replication, recombination, repair and expression of DNA and RNA genomes.

Authors:  A E Gorbalenya; E V Koonin; A P Donchenko; V M Blinov
Journal:  Nucleic Acids Res       Date:  1989-06-26       Impact factor: 16.971

View more
  33 in total

1.  Optimization of potent hepatitis C virus NS3 helicase inhibitors isolated from the yellow dyes thioflavine S and primuline.

Authors:  Kelin Li; Kevin J Frankowski; Craig A Belon; Ben Neuenswander; Jean Ndjomou; Alicia M Hanson; Matthew A Shanahan; Frank J Schoenen; Brian S J Blagg; Jeffrey Aubé; David N Frick
Journal:  J Med Chem       Date:  2012-03-22       Impact factor: 7.446

2.  The nonstructural protein 3 protease/helicase requires an intact protease domain to unwind duplex RNA efficiently.

Authors:  David N Frick; Ryan S Rypma; Angela M I Lam; Baohua Gu
Journal:  J Biol Chem       Date:  2003-10-29       Impact factor: 5.157

Review 3.  Understanding helicases as a means of virus control.

Authors:  D N Frick; A M I Lam
Journal:  Curr Pharm Des       Date:  2006       Impact factor: 3.116

4.  Ebola virus VP35 has novel NTPase and helicase-like activities.

Authors:  Ting Shu; Tianyu Gan; Peng Bai; Xiaotong Wang; Qi Qian; Hui Zhou; Qi Cheng; Yang Qiu; Lei Yin; Jin Zhong; Xi Zhou
Journal:  Nucleic Acids Res       Date:  2019-06-20       Impact factor: 16.971

5.  RNA localization to the Balbiani body in Xenopus oocytes is regulated by the energy state of the cell and is facilitated by kinesin II.

Authors:  Bianca Heinrich; James O Deshler
Journal:  RNA       Date:  2009-02-17       Impact factor: 4.942

6.  The protease domain increases the translocation stepping efficiency of the hepatitis C virus NS3-4A helicase.

Authors:  Vaishnavi Rajagopal; Madhura Gurjar; Mikhail K Levin; Smita S Patel
Journal:  J Biol Chem       Date:  2010-04-02       Impact factor: 5.157

Review 7.  Helicases as antiviral drug targets.

Authors:  David N Frick
Journal:  Drug News Perspect       Date:  2003 Jul-Aug

8.  Monitoring helicase activity with molecular beacons.

Authors:  Craig A Belon; David N Frick
Journal:  Biotechniques       Date:  2008-10       Impact factor: 1.993

9.  Deciphering the molecular basis for nucleotide selection by the West Nile virus RNA helicase.

Authors:  Simon Despins; Moheshwarnath Issur; Isabelle Bougie; Martin Bisaillon
Journal:  Nucleic Acids Res       Date:  2010-04-25       Impact factor: 16.971

10.  Primuline derivatives that mimic RNA to stimulate hepatitis C virus NS3 helicase-catalyzed ATP hydrolysis.

Authors:  Noreena L Sweeney; William R Shadrick; Sourav Mukherjee; Kelin Li; Kevin J Frankowski; Frank J Schoenen; David N Frick
Journal:  J Biol Chem       Date:  2013-05-23       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.